Oncolix Inc. (fka ONCX)

[nonewname1]

There may be some uncertainty about, for instance, they may have just finished a clinical trial for Prolanta.

https://clinicaltrials.gov/ct2/show/results/NCT02534922

Maybe it didn't go so well? But why would they be going public after a failed trial, all of their drugs seem to be related to this same type of cancer treatment.

Some might be worried about a potential R/S, but the share structure is pretty low and the new ceo owns 60 mil so that seems unlikely (though possible?)

People want details. I'm just hoping the trial went well. Prolanta has orphan drug designation so that means:

- Seven-year marketing exclusivity to the first sponsor obtaining FDA approval of a designated drug
- Tax credit equal to 50% of clinical investigation expenses
- Exemption/Waiver of PDUFA application (filing) fees
- Assistance in the drug development process
- Orphan Products Grant funding

They've already been able to get millions in financing so there must be some promise there.